| Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies. | None |
| Identification and characterization of a novel enhancer for the human MCT-1 oncogene promoter. | None |
| MCT-1 oncogene contributes to increased in vivo tumorigenicity of MCF7 cells by promotion of angiogenesis and inhibition of apoptosis. | None |
| MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage. | None |
| Expression and purification of recombinant human MCT-1 oncogene in insect cells. | None |
| The involvement of MCT-1 oncoprotein in inducing mitotic catastrophe and nuclear abnormalities. | None |
| Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity. | None |
| The oncogene mcts1. | None |
| A novel candidate oncogene, MCT-1, is involved in cell cycle progression. | None |